Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3373-3389.e16
Open Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Microbiome as a predictive biomarker in locally advanced rectal cancer
N. Mulet Margalef, Berta Martín, Eva Martinez‐Balibrea, et al.
Microbiome Research Reports (2025) Vol. 4, Iss. 2
Open Access
Innovative, early-phase clinical trials of drug–radiotherapy combinations
Antonin Lévy, Christophe Massard, Stefan Michiels, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 4, pp. e190-e202
Closed Access
Unlocking the power of the microbiome for successful cancer immunotherapy
Maria Alejandra Clavijo-Salomon, Giorgio Trinchieri
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011281-e011281
Open Access
Microbiota, chronic inflammation, and health: The promise of inflammatome and inflammatomics for precision medicine and healthcare
Huan Zhang, B. J. Yang Lee, Tong Wang, et al.
hLife (2025)
Open Access
From geroscience to precision geromedicine: Understanding and managing aging
Guido Kroemer, Andrea B. Maier, Ana María Cuervo, et al.
Cell (2025) Vol. 188, Iss. 8, pp. 2043-2062
Closed Access
The methionine cycle and its cancer implications
Valentina Tassinari, Jia Wang, Wen‐Lian Chen, et al.
Oncogene (2024) Vol. 43, Iss. 48, pp. 3483-3488
Closed Access | Times Cited: 3
The gut-brain axis in depression: Are multi-omics showing the way?
Jane A. Foster, Madhukar H. Trivedi
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101741-101741
Open Access | Times Cited: 2
Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies
Hamidreza Farhadi Rad, Hamed Tahmasebi, Samaneh Javani, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2776-2776
Open Access | Times Cited: 2
Leveraging human microbiomes for disease prediction and treatment
Henok Ayalew Tegegne, Tor Savidge
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 2
Gut microbiome discovery provides roadmap for life-saving cancer therapies
Giorgia Guglielmi
Nature (2024)
Closed Access | Times Cited: 1
Towards enhancing the predictive value of the microbiota for cancer immunotherapy
Amiran Dzutsev, Romina S. Goldszmid
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 771-773
Closed Access | Times Cited: 1
Impact of the Lung Microbiota on Development and Progression of Lung Cancer
Amine Belaïd, Barnabé Roméo, Guylène Rignol, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3342-3342
Open Access | Times Cited: 1
Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial
Marius Bredon, Karine le Malicot, Christophe Louvet, et al.
Gastroenterology (2024)
Open Access | Times Cited: 1
Intestinal microbiome and myelodysplastic syndromes: current state of knowledge and perspectives for future
Marin Simunic, Kathy L. McGraw, Steven Z. Pavletic, et al.
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
Redefining the Gastric Microbes in Promoting Gastric Tumorigenesis: The Rise of the Non–H. pylori Microbiome
Chi Chun Wong, Jun Yu
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2051-2054
Closed Access | Times Cited: 1
Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy
Lijun Ning, Jie Hong
Cell (2024) Vol. 187, Iss. 13, pp. 3231-3232
Closed Access
Emergent metabolic interactions in resistance toClostridioides difficileinvasion
Achuthan Ambat, Naomi Iris van den Berg, Francisco Zorrilla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nichtkleinzelliges Lungenkarzinom: Chancen der Immuntherapie aus Mikrobiom errechnen
Rüdiger Meyer
Deutsches Ärzteblatt (2024)
Closed Access
Relationship between energetic gap and sensitivity to anti- programmed cell death 1 immune checkpoint inhibitors in non-small cell lung cancer patients: The ELY-2 Study.
Manuela Tiako Meyo, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, et al.
Clinical Nutrition ESPEN (2024) Vol. 64, pp. 44-50
Closed Access
Longitudinal Fecal Microbiota Profiles in A Cohort of Non-Hospitalized Adolescents and Young Adults with COVID-19: Associations with SARS-CoV-2 Status and Long-Term Fatigue
Christine Olbjørn, Milada Hagen, Aina Elisabeth Fossum Moen, et al.
Pathogens (2024) Vol. 13, Iss. 11, pp. 953-953
Open Access
Quoi de neuf en recherche ?
Alexandra‐Chloé Villani
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S13-8S20
Closed Access
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 th immunorad conference
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
OncoImmunology (2024) Vol. 14, Iss. 1
Open Access
Previous Page - Page 2

Scroll to top